Plain-English translation of NCT05982496 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether a specialized imaging scan called 18F- PET/MRI can help doctors better understand which lymph nodes in the armpit are affected by breast cancer. The scan combines two types of imaging to get detailed information. This information could help doctors decide on the best surgical treatment plan without needing to remove as many lymph nodes.
Currently, doctors often have to surgically remove lymph nodes to determine if breast cancer has spread to the armpit. This trial exists to see if the new imaging scan can do this job more accurately, potentially sparing some patients from unnecessary surgery.
You likely qualify if…
You likely don't qualify if…
You would undergo the specialized 18F- PET/MRI imaging scan, which combines two scanning technologies to create detailed pictures of your breast and lymph nodes. Your results from this scan would be compared with what doctors find during your planned surgery. The study will help researchers understand whether this new imaging method can accurately detect cancer in the lymph nodes.
AI-generated summary from trial data · Aug 14, 2026 · Not medical advice
Italy
Phase
Testing effectiveness
Sponsor
Università Vita-Salute San Raffaele
Collaborators
IRCCS San Raffaele
Enrollment target
~119 participants
Started
June 2026
Primary completion
June 2029
Age range
18 Years and older
Sex
Female only
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Rosa Di Micco, MD
Università Vita-Salute San Raffaele
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.